{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:18:55Z","timestamp":1791307135249,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11883-014-0423-3","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T07:00:34Z","timestamp":1398754834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Update on Primary Hypobetalipoproteinemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Amanda J.","family":"Hooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"423_CR1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10408360500295113","volume":"42","author":"AJ Hooper","year":"2005","unstructured":"Hooper AJ, van Bockxmeer FM, Burnett JR. Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism. Crit Rev Clin Lab Sci. 2005;42:515\u201345.","journal-title":"Crit Rev Clin Lab Sci."},{"key":"423_CR2","author":"JR Burnett","year":"2012","unstructured":"Burnett JR, Bell DA, Hooper AJ, Hegele RA. Clinical utility gene card for: abetalipoproteinaemia. Eur J Hum Genet. 2012. doi: 10.1038\/ejhg.2012.30 .","journal-title":"Eur J Hum Genet."},{"key":"423_CR3","author":"JR Burnett","year":"2012","unstructured":"Burnett JR, Bell DA, Hooper AJ, Hegele RA. Clinical utility gene card for: familial hypobetalipoproteinaemia (APOB). Eur J Hum Genet. 2012. doi: 10.1038\/ejhg.2012.85 .","journal-title":"Eur J Hum Genet"},{"key":"423_CR4","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley Jr TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354:1264\u201372.","journal-title":"N Engl J Med."},{"key":"423_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","volume":"37","author":"J Cohen","year":"2005","unstructured":"Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet. 2005;37:161\u20135.","journal-title":"Nat Genet."},{"key":"423_CR6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.atherosclerosis.2006.08.039","volume":"193","author":"AJ Hooper","year":"2007","unstructured":"Hooper AJ, Marais AD, Tanyanyiwa DM, Burnett JR. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population. Atherosclerosis. 2007;193:445\u20138.","journal-title":"Atherosclerosis."},{"key":"423_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-5-24","volume":"5","author":"N Peretti","year":"2010","unstructured":"Peretti N, Sassolas A, Roy CC, et al. Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. Orphanet J Rare Dis. 2010;5:24.","journal-title":"Orphanet J Rare Dis."},{"key":"423_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MOL.0b013e32835ca0d9","volume":"24","author":"AJ Hooper","year":"2013","unstructured":"Hooper AJ, Burnett JR. Recent developments in the genetics of LDL deficiency. Curr Opin Lipidol. 2013;24:111\u20135.","journal-title":"Curr Opin Lipidol."},{"key":"423_CR9","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","volume":"363","author":"K Musunuru","year":"2010","unstructured":"Musunuru K, Pirruccello JP, Do R, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010;363:2220\u20137.","journal-title":"N Engl J Med."},{"key":"423_CR10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1126\/science.1439810","volume":"258","author":"JR Wetterau","year":"1992","unstructured":"Wetterau JR, Aggerbeck LP, Bouma ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 1992;258:999\u20131001.","journal-title":"Science."},{"key":"423_CR11","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/2.12.2109","volume":"2","author":"CC Shoulders","year":"1993","unstructured":"Shoulders CC, Brett DJ, Bayliss JD, et al. Abetalipoproteinemia is caused by defects of the gene encoding the 97\u00a0kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet. 1993;2:2109\u201316.","journal-title":"Hum Mol Genet."},{"key":"423_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1743-7075-9-14","volume":"9","author":"MM Hussain","year":"2012","unstructured":"Hussain MM, Rava P, Walsh M, Rana M, Iqbal J. Multiple functions of microsomal triglyceride transfer protein. Nutr Metab (Lond). 2012;9:14.","journal-title":"Nutr Metab (Lond)"},{"key":"423_CR13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-2275(20)33426-X","volume":"41","author":"K Ohashi","year":"2000","unstructured":"Ohashi K, Ishibashi S, Osuga J, et al. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J Lipid Res. 2000;41:1199\u2013204.","journal-title":"J Lipid Res."},{"key":"423_CR14","doi-asserted-by":"crossref","first-page":"29945","DOI":"10.1074\/jbc.271.47.29945","volume":"271","author":"EF Rehberg","year":"1996","unstructured":"Rehberg EF, Samson-Bouma ME, Kienzle B, et al. A novel abetalipoproteinemia genotype. Identification of a missense mutation in the 97-kDa subunit of the microsomal triglyceride transfer protein that prevents complex formation with protein disulfide isomerase. J Biol Chem. 1996;271:29945\u201352.","journal-title":"J Biol Chem."},{"key":"423_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev.nutr.20.1.663","volume":"20","author":"N Berriot-Varoqueaux","year":"2000","unstructured":"Berriot-Varoqueaux N, Aggerbeck LP, Samson-Bouma M, Wetterau JR. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr. 2000;20:663\u201397.","journal-title":"Annu Rev Nutr."},{"key":"423_CR16","first-page":"2717","volume-title":"The metabolic and molecular bases of inherited disease","author":"JP Kane","year":"2001","unstructured":"Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Scriver CR, Beaudet AL, Sly WS, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p. 2717\u201352."},{"key":"423_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0028-1098264","volume":"10","author":"G Delpre","year":"1978","unstructured":"Delpre G, Kadish U, Glantz I, Avidor I. Endoscopic assessment in abetalipoproteinemia (Bassen-Kornzweig-syndrome). Endoscopy. 1978;10:59\u201362.","journal-title":"Endoscopy."},{"key":"423_CR18","first-page":"197","volume":"55","author":"MC Tanyel","year":"1997","unstructured":"Tanyel MC, Mancano LD. Neurologic findings in vitamin E deficiency. Am Fam Physician. 1997;55:197\u2013201.","journal-title":"Am Fam Physician."},{"key":"423_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-3-19","volume":"3","author":"R Zamel","year":"2008","unstructured":"Zamel R, Khan R, Pollex RL, Hegele RA. Abetalipoproteinemia: two case reports and literature review. Orphanet J Rare Dis. 2008;3:19.","journal-title":"Orphanet J Rare Dis."},{"key":"423_CR20","doi-asserted-by":"crossref","unstructured":"Lee J, Hegele RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J Inherit Metab Dis. 2014. doi: 10.1007\/s10545-013-9665-4 . This article discusses the diagnosis, assessment, treatment, and follow-up of ABL and homozygous FHBL.","DOI":"10.1007\/s10545-013-9665-4"},{"key":"423_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/eye.2001.167","volume":"15","author":"I Chowers","year":"2001","unstructured":"Chowers I, Banin E, Merin S, Cooper M, Granot E. Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients. Eye. 2001;15:525\u201330.","journal-title":"Eye."},{"key":"423_CR22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mnfr.200900460","volume":"54","author":"DP Muller","year":"2010","unstructured":"Muller DP. Vitamin E, and neurological function. Mol Nutr Food Res. 2010;54:710\u20138.","journal-title":"Mol Nutr Food Res."},{"key":"423_CR23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-2275(20)37971-2","volume":"24","author":"HJ Kayden","year":"1983","unstructured":"Kayden HJ, Hatam LJ, Traber MG. The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: normal and abetalipoproteinemic subjects. J Lipid Res. 1983;24:652\u20136.","journal-title":"J Lipid Res."},{"key":"423_CR24","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1373\/clinchem.2006.068692","volume":"52","author":"MW Clarke","year":"2006","unstructured":"Clarke MW, Hooper AJ, Headlam HA, Wu JH, Croft KD, Burnett JR. Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia. Clin Chem. 2006;52:1339\u201345.","journal-title":"Clin Chem."},{"key":"423_CR25","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00018-005-4473-0","volume":"62","author":"G Schonfeld","year":"2005","unstructured":"Schonfeld G, Lin X, Yue P. Familial hypobetalipoproteinemia: genetics and metabolism. Cell Mol Life Sci. 2005;62:1372\u20138.","journal-title":"Cell Mol Life Sci."},{"key":"423_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-387025-4.00004-2","volume":"54","author":"P Tarugi","year":"2011","unstructured":"Tarugi P, Averna M. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv Clin Chem. 2011;54:81\u2013107.","journal-title":"Adv Clin Chem."},{"key":"423_CR27","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2004.038026","volume":"50","author":"AJ Whitfield","year":"2004","unstructured":"Whitfield AJ, Barrett PHR, van Bockxmeer FM, Burnett JR. Lipid disorders and mutations in the APOB gene. Clin Chem. 2004;50:1725\u201332.","journal-title":"Clin Chem."},{"key":"423_CR28","doi-asserted-by":"crossref","first-page":"13442","DOI":"10.1074\/jbc.M300235200","volume":"278","author":"JR Burnett","year":"2003","unstructured":"Burnett JR, Shan J, Miskie BA, et al. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia. J Biol Chem. 2003;278:13442\u201352.","journal-title":"J Biol Chem."},{"key":"423_CR29","doi-asserted-by":"crossref","first-page":"24270","DOI":"10.1074\/jbc.M702442200","volume":"282","author":"JR Burnett","year":"2007","unstructured":"Burnett JR, Zhong S, Jiang ZG, et al. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of apoB and apoB-containing lipoproteins in familial hypobetalipoproteinemia. J Biol Chem. 2007;282:24270\u201383.","journal-title":"J Biol Chem."},{"key":"423_CR30","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1074\/jbc.M109.060467","volume":"285","author":"S Zhong","year":"2010","unstructured":"Zhong S, Magnolo AL, Sundaram M, et al. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia - evidence for feedback inhibition of lipogenesis and post-endoplasmic reticulum degradation of apolipoprotein B. J Biol Chem. 2010;285:6453\u201364.","journal-title":"J Biol Chem."},{"key":"423_CR31","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/01.ATV.19.11.2714","volume":"19","author":"N Elias","year":"1999","unstructured":"Elias N, Patterson BW, Schonfeld G. Decreased production rates of VLDL triglycerides and apoB-100 in subjects heterozygous for familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 1999;19:2714\u201321.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"423_CR32","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/S0021-9258(18)49988-7","volume":"266","author":"ZM Yao","year":"1991","unstructured":"Yao ZM, Blackhart BD, Linton MF, Taylor SM, Young SG, McCarthy BJ. Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells. Evidence that the length of apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins. J Biol Chem. 1991;266:3300\u20138.","journal-title":"J Biol Chem."},{"key":"423_CR33","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1194\/jlr.R026658","volume":"53","author":"G Lambert","year":"2012","unstructured":"Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK. The PCSK9 decade. J Lipid Res. 2012;53:2515\u201324.","journal-title":"J Lipid Res"},{"key":"423_CR34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","volume":"79","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Tuakli-Wosornu Y, Lagace TA, et al. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am J Hum Genet. 2006;79:514\u201323.","journal-title":"Am J Hum Genet."},{"key":"423_CR35","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/ATVBAHA.109.194191","volume":"29","author":"B Cariou","year":"2009","unstructured":"Cariou B, Ouguerram K, Zair Y, et al. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 2009;29:2191\u20137.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"423_CR36","first-page":"339","volume":"92","author":"H Ogata","year":"1997","unstructured":"Ogata H, Akagi K, Baba M, et al. Fatty liver in a case with heterozygous familial hypobetalipoproteinemia. Am J Gastroenterol. 1997;92:339\u201342.","journal-title":"Am J Gastroenterol."},{"key":"423_CR37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1194\/jlr.M200342-JLR200","volume":"44","author":"G Schonfeld","year":"2003","unstructured":"Schonfeld G, Patterson BW, Yablonskiy DA, et al. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J Lipid Res. 2003;44:470\u20138.","journal-title":"J Lipid Res."},{"key":"423_CR38","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.0000176191.64314.07","volume":"25","author":"RR Sankatsing","year":"2005","unstructured":"Sankatsing RR, Fouchier SW, de Haan S, et al. Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 2005;25:1979\u201384.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"423_CR39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1194\/jlr.M300508-JLR200","volume":"45","author":"T Tanoli","year":"2004","unstructured":"Tanoli T, Yue P, Yablonskiy D, Schonfeld G. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res. 2004;45:941\u20137.","journal-title":"J Lipid Res."},{"key":"423_CR40","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00125-011-2157-x","volume":"54","author":"ME Visser","year":"2011","unstructured":"Visser ME, Lammers NM, Nederveen AJ, et al. Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia. 2011;54:2113\u201321.","journal-title":"Diabetologia."},{"key":"423_CR41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1194\/jlr.R008896","volume":"52","author":"AJ Hooper","year":"2011","unstructured":"Hooper AJ, Adams LA, Burnett JR. Genetic determinants of hepatic steatosis in man. J Lipid Res. 2011;52:593\u2013617.","journal-title":"J Lipid Res."},{"key":"423_CR42","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1023\/A:1026646618643","volume":"43","author":"A Lonardo","year":"1998","unstructured":"Lonardo A, Tarugi P, Ballarini G, Bagni A. Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma. Dig Dis Sci. 1998;43:2489\u201392.","journal-title":"Dig Dis Sci."},{"key":"423_CR43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0168-8278(00)80270-6","volume":"33","author":"P Tarugi","year":"2000","unstructured":"Tarugi P, Lonardo A, Ballarini G, et al. A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5). J Hepatol. 2000;33:361\u201370.","journal-title":"J Hepatol."},{"key":"423_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng1145","volume":"34","author":"B Jones","year":"2003","unstructured":"Jones B, Jones EL, Bonney SA, et al. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet. 2003;34:29\u201331.","journal-title":"Nat Genet."},{"key":"423_CR45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1242\/jcs.00215","volume":"116","author":"SA Siddiqi","year":"2003","unstructured":"Siddiqi SA, Gorelick FS, Mahan JT, Mansbach 2nd CM. COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle. J Cell Sci. 2003;116:415\u201327.","journal-title":"J Cell Sci."},{"key":"423_CR46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ymgme.2009.02.003","volume":"97","author":"N Peretti","year":"2009","unstructured":"Peretti N, Roy CC, Sassolas A, et al. Chylomicron retention disease: a long term study of two cohorts. Mol Genet Metab. 2009;97:136\u201342.","journal-title":"Mol Genet Metab."},{"key":"423_CR47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1258\/acb.2010.009307","volume":"47","author":"K Nakajima","year":"2010","unstructured":"Nakajima K, Kobayashi J, Mabuchi H, et al. Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma. Ann Clin Biochem. 2010;47:423\u201331.","journal-title":"Ann Clin Biochem."},{"key":"423_CR48","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1074\/jbc.M808477200","volume":"284","author":"L Shan","year":"2009","unstructured":"Shan L, Yu XC, Liu Z, et al. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem. 2009;284:1419\u201324.","journal-title":"J Biol Chem."},{"key":"423_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2796.1991.tb00304.x","volume":"229","author":"S Fazio","year":"1991","unstructured":"Fazio S, Sidoli A, Vivenzio A, et al. A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene. J Intern Med. 1991;229:41\u20137.","journal-title":"J Intern Med."},{"key":"423_CR50","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-1298","volume":"97","author":"I Minicocci","year":"2012","unstructured":"Minicocci I, Montali A, Robciuc MR, et al. Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. J Clin Endocrinol Metab. 2012;97:E1266\u201375.","journal-title":"J Clin Endocrinol Metab."},{"key":"423_CR51","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.P039875","volume":"54","author":"I Minicocci","year":"2013","unstructured":"Minicocci I, Santini S, Cantisani V, et al. Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. J Lipid Res. 2013;54:3481\u201390.","journal-title":"J Lipid Res."},{"key":"423_CR52","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.113.301397","volume":"33","author":"MR Robciuc","year":"2013","unstructured":"Robciuc MR, Maranghi M, Lahikainen A, et al. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol. 2013;33:1706\u201313. This article shows that although partial deficiency of ANGPTL3 did not affect lipase activity, complete deficiency decreased the levels of free fatty acids and improved insulin sensitivity.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"423_CR53","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.ijcard.2013.05.053","volume":"168","author":"I Minicocci","year":"2013","unstructured":"Minicocci I, Cantisani V, Poggiogalle E, et al. Functional and morphological vascular changes in subjects with familial combined hypolipidemia: an exploratory analysis. Int J Cardiol. 2013;168:4375\u20138. Despite an approximately 50% reduction in the concentration of LDL cholesterol, ANGPTL3 homozygotes had increased CIMT.","journal-title":"Int J Cardiol"},{"key":"423_CR54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/ATVBAHA.111.238766","volume":"32","author":"D Noto","year":"2012","unstructured":"Noto D, Cefalu AB, Valenti V, et al. Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia. Arterioscler Thromb Vasc Biol. 2012;32:805\u20139.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"423_CR55","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/ATVBAHA.112.245076","volume":"32","author":"K Ouguerram","year":"2012","unstructured":"Ouguerram K, Zair Y, Kasbi-Chadli F, et al. Low rate of production of apolipoproteins B100 and AI in 2 patients with Anderson disease (chylomicron retention disease). Arterioscler Thromb Vasc Biol. 2012;32:1520\u20135.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"423_CR56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","volume":"55","author":"CT Johansen","year":"2014","unstructured":"Johansen CT, Dube JB, Loyzer MN, et al. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias. J Lipid Res. 2014;55:765\u201372. This article describes the design and performance of a targeted resequencing panel which has potential to aid in molecular diagnosis of dyslipidemias, including primary HBL.","journal-title":"J Lipid Res"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-014-0423-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-014-0423-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-014-0423-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:18:03Z","timestamp":1648905483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-014-0423-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1007\/s11883-014-0423-3","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]},"article-number":"423"}}